-+ 0.00%
-+ 0.00%
-+ 0.00%

APREA THERAPEUTICS INC -DOSING OF PATIENT WITH HPV+ HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) IN ONGOING ACESOT-1051 TRIAL

Reuters·03/31/2025 12:36:47

Please log in to view news